in Newswire March 6, 2018

Class Action Claims Pharma Companies Responsible for NAS Due to Opioid Use

by Erin Shaak

Last Updated on March 6, 2018

Rees et al v. Mckesson Corporation et al

Filed: February 28, 2018 § 3:18cv511

A group of 20 pharmaceutical companies and distributors has been named in a proposed class action lawsuit filed on behalf of a newborn baby who the suit claims suffers from neonatal abstinence syndrome (NAS) as a result of the defendants’ actions.

Last Updated on March 6, 2018 — 4:03 PM

Erin Shaak

Erin works primarily on’s newswire, reporting on cases as they happen.

About is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.